C Méndez-Hernández. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Abnormalities, Drug-Induced/prevention & controlAdministration, OphthalmicAdministration, OralAdrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/therapeutic useAnimalsBrimonidine TartrateCarbonic Anhydrase Inhibitors/administration & dosageCarbonic Anhydrase Inhibitors/adverse effectsCarbonic Anhydrase Inhibitors/therapeutic useContraindicationsFemaleFetus/drug effectsGelsGlaucoma/drug therapyGlaucoma/physiopathologyGlaucoma/surgeryHumansHypotension/chemically inducedIntraocular PressureLactationObstetric Labor, Premature/prevention & controlOphthalmic SolutionsPregnancyPregnancy Complications/drug therapyPregnancy Complications/physiopathologyPregnancy Complications/surgeryProstaglandins/therapeutic useQuinoxalines/adverse effectsQuinoxalines/therapeutic useTimolol/administration & dosageTimolol/adverse effectsTimolol/therapeutic use
Substances： See more » Adrenergic beta-AntagonistsCarbonic Anhydrase InhibitorsGelsOphthalmic SolutionsProstaglandinsQuinoxalinesBrimonidine TartrateTimolol
Year: 2012 PMID： 23121698 DOI： 10.1016/j.oftal.2012.10.005
Source DB: PubMed Journal: Arch Soc Esp Oftalmol ISSN： 0365-6691